Cielo-Blu Group Ltd (TLV:CILO)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	322	444	66	374	883	486
Market Cap Growth	576.36%	574.10%	-82.40%	-57.65%	81.65%	22.25%
Enterprise Value	676	876	2,956	3,344	2,148	1,300
Last Close Price	4.11	5.65	37.98	213.30	569.83	354.99
PE Ratio	0.74	1.37	-	3.18	4.91	-
PS Ratio	1.72	1.94	0.16	0.46	1.41	2.41
PB Ratio	1.06	1.47	-0.52	0.50	1.41	2.37
P/TBV Ratio	1.06	1.48	-	0.56	1.59	2.39
P/FCF Ratio	21.34	2.91	-	-	-	-
P/OCF Ratio	20.62	2.89	-	-	-	-
EV/Sales Ratio	3.60	3.83	7.38	4.10	3.42	6.45
EV/EBITDA Ratio	104.27	-	495.41	22.58	17.38	80.06
EV/EBIT Ratio	184.49	-	2515.40	23.09	17.91	105.30
EV/FCF Ratio	44.79	5.73	-	-	-	-
Debt / Equity Ratio	1.22	1.29	-21.09	3.92	5.15	4.76
Debt / EBITDA Ratio	29.65	-	444.87	19.78	26.14	60.17
Debt / FCF Ratio	24.52	2.56	-	-	-	-
Asset Turnover	0.11	0.12	0.11	0.19	0.21	0.15
Inventory Turnover	0.19	0.20	0.17	0.26	0.29	0.25
Quick Ratio	0.54	0.44	0.06	0.09	0.10	0.08
Current Ratio	1.25	1.24	0.82	1.05	1.09	0.89
Return on Equity (ROE)	1176.80%	372.27%	-277.39%	18.39%	43.29%	-2.83%
Return on Assets (ROA)	0.35%	-0.39%	0.02%	2.13%	2.54%	0.56%
Return on Capital (ROIC)	0.43%	-0.47%	0.02%	2.40%	2.97%	0.68%
Return on Capital Employed (ROCE)	1.50%	-	1.50%	10.00%	7.30%	3.40%
Earnings Yield	135.46%	73.25%	-1320.39%	31.45%	20.38%	-1.21%
FCF Yield	4.69%	34.41%	-241.50%	-43.73%	-169.70%	-17.48%
Dividend Yield	-	-	-	-	0.51%	0.75%
Payout Ratio	-	-	-	5.53%	2.78%	-
Buyback Yield / Dilution	-	-1371.19%	-0.02%	-16.43%	-10.07%	-3.55%
Total Shareholder Return	-	-1371.19%	-0.02%	-16.43%	-9.56%	-2.79%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.